Navigation Links
Joint Commission Recognizes Spectrum Healthcare Resources
Date:9/1/2009

KNOXVILLE, Tenn., Sept. 1 /PRNewswire/ -- Spectrum Healthcare Resources (Spectrum) recently passed The Joint Commission's intra-cycle certification, a program that offers an independent, comprehensive evaluation of a staffing firm's ability to provide competent staffing services. This certification follows Spectrum's third consecutive Gold Seal of Approval, which the organization received in 2008.

"Healthcare organizations that contract with Spectrum can look to the intra-cycle certification as an assurance that Spectrum demonstrates a commitment to providing and continuously improving quality services," says Michele Sacco, M.S., executive director, Health Care Staffing Services Certification, Joint Commission.

As part of Spectrum's third Gold Seal of Approval, the organization underwent an unannounced, on-site review of its compliance with national standards addressing how staffing firms determine the qualifications and competency of their staff, how they place their staff, and how they monitor staff's performance.

"These awards recognize Spectrum's dedication to providing qualified healthcare professionals who provide safe, high-quality care to patients," says George Tracy, President, Spectrum. "We're proud to receive the Joint Commission's certification and Gold Seal of Approval."

About Spectrum Healthcare Resources

Spectrum is the leader of organizations that provide physicians, clinical personnel, and management services to military treatment facilities (MTFs) throughout the United States. Spectrum serves 126 MTFs and six Veterans Affairs (VA) facilities nationwide through various contracting vehicles, including TriCare. Spectrum provides these medical facilities with more than 400 physicians, 1,000 nurses, 250 mid-level providers, and 900 allied health professionals. A division of TeamHealth, Spectrum was established in 1988 to ensure that systems and processes are designed to meet the unique needs of the military health and VA systems.

About The Joint Commission

Founded in 1951, The Joint Commission seeks to continuously improve the safety and quality of care provided to the public through the provision of health care accreditation and related services that support performance improvement in health care organizations. The Joint Commission evaluates and accredits more than 15,000 health care organizations and programs in the United States, including more than 8,000 hospitals and home care organizations, and more than 6,800 other health care organizations that provide long term care, assisted living, behavioral health care, laboratory and ambulatory care services. The Joint Commission also accredits health plans, integrated delivery networks, and other managed care entities. In addition, the Joint Commission provides certification of disease-specific care programs, primary stroke centers, and health care staffing services. An independent, not-for-profit organization, the Joint Commission is the nation's oldest and largest standards-setting and accrediting body in health care. Learn more about the Joint Commission at www.jointcommission.org.


'/>"/>
SOURCE Spectrum Healthcare Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
2. Joint NJ/NY Rally for Addiction Recovery to Be Hub of Events Nationwide
3. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
4. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint
5. The impact of physical activity on weight-bearing knee joint
6. Joint Center Says New Approach Required to Reduce Black Infant Mortality
7. Merlyn Medical Announces FDA Approval for FlexWarmer in a Joint Agreement with Elltec and Suzuken
8. The Joint Commission Enhances Quality Check Website
9. OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction
10. More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints
11. Delaware Court Approves Bioenvision, Genzyme Joint Petition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... communities in the greater Dallas, Miami, and Raleigh regions, is organizing an extended ... overcome a rare and deadly chromosome abnormality. , After struggling since birth with ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology: